Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Wistuba

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Clinical Lung Cancer|July 19, 2016
Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin AmericaLuis E Raez, Edgardo S Santos, Christian Rolfo, et al.
Cancers|January 25, 2020
Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology StudiesEdwin Roger Parra, Mei Jiang, Luisa Solis, et al.
Nature|October 22, 2010
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAsXiaohua Su, Deepavali Chakravarti, Min Soon Cho, et al.
Nature|July 19, 2024
Author Correction: TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAsXiaohua Su, Deepavali Chakravarti, Min Soon Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Phase II study of dasatinib in patients with advanced non-small-cell lung cancerFaye M Johnson, B Nebiyou Bekele, Lei Feng, et al.
Oncotarget|July 8, 2016
Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutationsYuehong Wang, Ratnakar Singh, Liguang Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2018
Salvaging the supernatant: next generation cytopathology for solid tumor mutation profilingSinchita Roy-Chowdhuri, Meenakshi Mehrotra, Ana Maria Bolivar, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 7, 2009
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesionsAnne S Tsao, Diane Liu, Jack Martin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 16, 2013
Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
Oncotarget|December 17, 2016
The ISG15-specific protease USP18 regulates stability of PTENLisa Maria Mustachio, Masanori Kawakami, Yun Lu, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Clinical Lung Cancer|July 19, 2016
Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin AmericaLuis E Raez, Edgardo S Santos, Christian Rolfo, et al.
Cancers|January 25, 2020
Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology StudiesEdwin Roger Parra, Mei Jiang, Luisa Solis, et al.
Nature|October 22, 2010
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAsXiaohua Su, Deepavali Chakravarti, Min Soon Cho, et al.
Nature|July 19, 2024
Author Correction: TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAsXiaohua Su, Deepavali Chakravarti, Min Soon Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Phase II study of dasatinib in patients with advanced non-small-cell lung cancerFaye M Johnson, B Nebiyou Bekele, Lei Feng, et al.
Oncotarget|July 8, 2016
Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutationsYuehong Wang, Ratnakar Singh, Liguang Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2018
Salvaging the supernatant: next generation cytopathology for solid tumor mutation profilingSinchita Roy-Chowdhuri, Meenakshi Mehrotra, Ana Maria Bolivar, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 7, 2009
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesionsAnne S Tsao, Diane Liu, Jack Martin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 16, 2013
Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
Oncotarget|December 17, 2016
The ISG15-specific protease USP18 regulates stability of PTENLisa Maria Mustachio, Masanori Kawakami, Yun Lu, et al.
Pageof 13